Profile data is unavailable for this security.
About the company
ZhuZhou QianJin Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production, wholesaling and retailing of drugs. The Company's main products include tablets, granules, pills, hard capsules, syrups, herbs, vinum and gels, among others. The company is also involved in the businesses of cultural entertainment, logistics and distribution, as well as the provision of hygienic products.
- Revenue in CNY (TTM)3.80bn
- Net income in CNY320.41m
- Incorporated1993
- Employees5.34k
- LocationZhuZhou QianJin Pharmaceutical Co LtdNo.801 Zhuzhou Avenue, Tianyuan DistrictZHUZHOU 412000ChinaCHN
- Phone+86 73 122492897
- Fax+86 73 122496088
- Websitehttp://www.qjyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai No.1 Pharmacy Co Ltd | 1.82bn | 95.72m | 2.55bn | 870.00 | 26.62 | 2.45 | -- | 1.40 | 0.429 | 0.429 | 8.17 | 4.65 | 0.922 | 4.57 | 7.96 | 2,094,816.00 | 4.84 | 5.42 | 8.10 | 8.94 | 18.34 | 19.04 | 5.25 | 4.64 | 1.18 | -- | 0.2272 | 30.93 | -31.49 | 9.11 | -37.81 | 13.60 | 8.75 | 13.97 |
| HPGC Renmintongtai Pharmaceutical Corp | 10.33bn | 298.71m | 3.99bn | 2.96k | 13.36 | 1.41 | -- | 0.386 | 0.5151 | 0.5151 | 17.82 | 4.88 | 1.43 | 9.31 | 2.43 | 3,491,425.00 | 4.12 | 3.98 | 10.51 | 10.87 | 9.30 | 10.60 | 2.89 | 2.73 | 1.33 | 24.63 | 0.4598 | 12.28 | 7.77 | 8.05 | 10.47 | 2.53 | 32.58 | -- |
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.80bn | 320.41m | 5.03bn | 5.34k | 15.60 | 2.05 | -- | 1.32 | 0.7518 | 0.7518 | 8.90 | 5.71 | 0.8159 | 3.68 | 15.02 | 711,993.50 | 8.48 | 8.99 | 16.34 | 16.21 | 45.12 | 44.59 | 10.40 | 10.03 | 1.93 | -- | 0.1707 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
| JZJ Chain Drugstore Corp | 9.31bn | 449.03m | 6.32bn | 15.66k | 14.08 | 2.31 | -- | 0.6792 | 3.48 | 3.48 | 72.17 | 21.25 | 1.02 | 2.86 | 20.14 | 594,079.60 | 4.93 | 6.75 | 8.72 | 13.98 | 35.36 | 35.31 | 4.83 | 5.15 | 0.3475 | 5.23 | 0.5876 | 31.79 | 43.54 | 26.21 | 20.90 | 30.85 | 38.25 | -- |
| LBX Pharmacy Chain JSC | 22.54bn | 958.95m | 20.60bn | 40.88k | 21.48 | 2.92 | -- | 0.9142 | 1.64 | 1.64 | 38.53 | 12.08 | 1.06 | 3.61 | 11.24 | 551,261.10 | 5.40 | 5.73 | 11.29 | 12.96 | 32.73 | 32.33 | 5.11 | 5.08 | 0.4795 | 13.19 | 0.557 | 33.18 | 11.21 | 18.83 | 18.35 | 16.39 | -6.60 | 19.16 |
Data as of Mar 13 2024. Currency figures normalised to ZhuZhou QianJin Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
12.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Huatai-PineBridge Fund Management Co., Ltd.as of 31 Mar 2023 | 12.64m | 3.02% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 11.87m | 2.84% |
| Pacific Asset Management Co., Ltd.as of 31 Mar 2023 | 5.15m | 1.23% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2023 | 4.47m | 1.07% |
| Zhong Ou Asset Management Co., Ltdas of 31 Mar 2023 | 4.13m | 0.99% |
| China Fund Management Co., Ltd.as of 31 Mar 2023 | 4.00m | 0.96% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2023 | 3.87m | 0.93% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 3.28m | 0.78% |
| Hotland Innovation Asset Management Co. Ltd.as of 30 Jun 2023 | 1.64m | 0.39% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2023 | 1.43m | 0.34% |
More ▼
Data from 30 Jun 2023 - 27 Mar 2024Source: FactSet Research Systems Inc.
